These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 24778153)

  • 1. Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL.
    Wang L; Shalek AK; Lawrence M; Ding R; Gaublomme JT; Pochet N; Stojanov P; Sougnez C; Shukla SA; Stevenson KE; Zhang W; Wong J; Sievers QL; MacDonald BT; Vartanov AR; Goldstein NR; Neuberg D; He X; Lander E; Hacohen N; Regev A; Getz G; Brown JR; Park H; Wu CJ
    Blood; 2014 Aug; 124(7):1089-98. PubMed ID: 24778153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.
    Lu D; Liu JX; Endo T; Zhou H; Yao S; Willert K; Schmidt-Wolf IG; Kipps TJ; Carson DA
    PLoS One; 2009 Dec; 4(12):e8294. PubMed ID: 20011538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dishevelled proteins are significantly upregulated in chronic lymphocytic leukaemia.
    Khan AS; Hojjat-Farsangi M; Daneshmanesh AH; Hansson L; Kokhaei P; Österborg A; Mellstedt H; Moshfegh A
    Tumour Biol; 2016 Sep; 37(9):11947-11957. PubMed ID: 27086035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant splicing of the E-cadherin transcript is a novel mechanism of gene silencing in chronic lymphocytic leukemia cells.
    Sharma S; Lichtenstein A
    Blood; 2009 Nov; 114(19):4179-85. PubMed ID: 19745069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway.
    Li PP; Feng LL; Chen N; Ge XL; Lv X; Lu K; Ding M; Yuan D; Wang X
    Med Oncol; 2015 Feb; 32(2):479. PubMed ID: 25575438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the Wnt signaling pathway in chronic lymphocytic leukemia.
    Lu D; Zhao Y; Tawatao R; Cottam HB; Sen M; Leoni LM; Kipps TJ; Corr M; Carson DA
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3118-23. PubMed ID: 14973184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Old and new news in CLL: "It's the pathway, stupid!".
    Egle A
    Blood; 2014 Aug; 124(7):989-90. PubMed ID: 25124780
    [No Abstract]   [Full Text] [Related]  

  • 8. Variation in WNT genes expression in different subtypes of chronic lymphocytic leukemia.
    Memarian A; Hojjat-Farsangi M; Asgarian-Omran H; Younesi V; Jeddi-Tehrani M; Sharifian RA; Khoshnoodi J; Razavi SM; Rabbani H; Shokri F
    Leuk Lymphoma; 2009 Dec; 50(12):2061-70. PubMed ID: 19863181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased WNT3 expression in chronic lymphocytic leukaemia is a hallmark of disease progression and identifies patients with worse prognosis in the subgroup with mutated IGHV.
    Poppova L; Janovska P; Plevova K; Radova L; Plesingerova H; Borsky M; Kotaskova J; Kantorova B; Hlozkova M; Figulova J; Brychtova Y; Machalova M; Urik M; Doubek M; Kozubik A; Pospisilova S; Pavlova S; Bryja V
    Br J Haematol; 2016 Dec; 175(5):851-859. PubMed ID: 27651098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockage of Wnt/β-Catenin Signaling by Nanoparticles Reduces Survival and Proliferation of CLL Cells In Vitro-Preliminary Study.
    Franiak-Pietryga I; Maciejewski H; Ziemba B; Appelhans D; Voit B; Robak T; Jander M; Treliński J; Bryszewska M; Borowiec M
    Macromol Biosci; 2017 Nov; 17(11):. PubMed ID: 28762636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic dysregulation of the Wnt signalling pathway in chronic lymphocytic leukaemia.
    Chim CS; Pang R; Liang R
    J Clin Pathol; 2008 Nov; 61(11):1214-9. PubMed ID: 18765431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis.
    Gutierrez A; Tschumper RC; Wu X; Shanafelt TD; Eckel-Passow J; Huddleston PM; Slager SL; Kay NE; Jelinek DF
    Blood; 2010 Oct; 116(16):2975-83. PubMed ID: 20595513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1.
    Liu P; Xu B; Shen W; Zhu H; Wu W; Fu Y; Chen H; Dong H; Zhu Y; Miao K; Xu W; Li J
    Leukemia; 2012 Jun; 26(6):1293-300. PubMed ID: 22157808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circular RNA circ-CBFB promotes proliferation and inhibits apoptosis in chronic lymphocytic leukemia through regulating miR-607/FZD3/Wnt/β-catenin pathway.
    Xia L; Wu L; Bao J; Li Q; Chen X; Xia H; Xia R
    Biochem Biophys Res Commun; 2018 Sep; 503(1):385-390. PubMed ID: 29902450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
    Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
    Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors.
    Jordaan G; Liao W; Sharma S
    BMC Cancer; 2013 Feb; 13():88. PubMed ID: 23432814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ON 01910.Na is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress.
    Chapman CM; Sun X; Roschewski M; Aue G; Farooqui M; Stennett L; Gibellini F; Arthur D; Pérez-Galán P; Wiestner A
    Clin Cancer Res; 2012 Apr; 18(7):1979-91. PubMed ID: 22351695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wnt/β-catenin/LEF-1 signaling in chronic lymphocytic leukemia (CLL): a target for current and potential therapeutic options.
    Gandhirajan RK; Poll-Wolbeck SJ; Gehrke I; Kreuzer KA
    Curr Cancer Drug Targets; 2010 Nov; 10(7):716-27. PubMed ID: 20578984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.